While LSR’s role in cancer remains incompletely understood, our anti-LSR mAb offers a valuable tool to investigate its contributions to tumorigenesis, metabolic reprogramming (67), and immune regulation (63, 68) in future studies. The gene discussed is LSR; the disease is cancer.